US Executive Compensation Proxy SEC Filings — June 17, 2026

17-06-2026

Deep Fission, Inc. (formerly Surfside Acquisition Inc.) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on July 17, 2026. The meeting will include the election of two Class I directors, ratification of Grant Thornton as independent auditor for fiscal 2026, and approval of an amendment to the 2025 Equity Incentive Plan to increase authorized shares by 5.0 million. As of the record date, there were 56,396,123 shares of common stock outstanding.

• · The company was formed via a reverse recapitalization merger with Surfside Acquisition Inc. in September 2025, changing name to Deep Fission, Inc.
• · Legacy Deep Fission was founded by Richard and Elizabeth Muller to develop advanced nuclear energy technologies.
• · Proxies must be submitted by 11:59 p.m. Eastern Time on July 16, 2026.
• · The annual meeting will be held virtually at www.virtualshareholdermeeting.com/FISN2026.
• · Proposal No. 1 (election of directors) requires a plurality vote; Proposals 2 and 3 require a majority of votes cast.
• · Broker non-votes are expected on Proposals 1 and 3 (non-routine); Proposal 2 (auditor ratification) is routine.

17-06-2026

Organon & Co. is soliciting stockholder approval for its acquisition by Sun Pharmaceutical Industries Ltd. via a merger with Sun Pharma USA's subsidiary, with stockholders to vote on the Merger Agreement Proposal and a non-binding advisory Compensation Proposal at a Special Meeting on July 23, 2026. The Board unanimously recommends voting FOR both proposals, and the merger consideration is based on the terms of the Merger Agreement dated April 26, 2026. Stockholders who fail to vote or abstain will effectively count as votes against the Merger Agreement Proposal, which requires approval by a majority of outstanding shares.

• · The Special Meeting will be held virtually on July 23, 2026 at 10:00 a.m. Eastern Time.
• · Record date for voting is June 15, 2026.
• · Approval of the Merger Agreement Proposal requires the affirmative vote of holders of a majority of outstanding shares of Organon common stock entitled to vote.
• · The Merger Agreement was dated April 26, 2026.
• · Organon was formed through a spinoff from Merck & Co., Inc. in 2021.
• · Organon's principal executive offices are at 30 Hudson Street, Floor 33, Jersey City, New Jersey 07302.
• · Sun Pharma USA's principal executive offices are at 2 Independence Way, Princeton, NJ 08540.
• · Merger Sub has not engaged in any business or operations except activities incidental to its formation and the merger.

17-06-2026

Venture Lending & Leasing IX, Inc. is seeking shareholder approval to liquidate and dissolve by distributing all remaining assets to its sole shareholder, Venture Lending & Leasing IX, LLC, and to terminate its status as a business development company (BDC). The fund, which raised $407.1M in capital and has distributed over $523.0M to date, retains approximately $59.3M in total assets as of March 31, 2026. The proposals aim to achieve cost savings by eliminating SEC reporting and separate audit expenses, but carry risks including potential taxable income without cash distributions and the fund's declining size threatening its RIC tax qualification.

• · Fund IX was organized in 2017.
• · The LLC is the sole shareholder of Fund IX and was organized in 2017.
• · The LLC's rights are governed by its Second Amended and Restated Operating Agreement dated December 15, 2017.
• · The LLC does not hold annual meetings of members.
• · The LLC is expected to wind down its business by December 31, 2030, subject to up to five one-year extensions.
• · The proposals are not expected to change the duties or compensation of Westech.
• · The LLC currently has an Advisory Board consisting of Roger V. Smith, Scott C. Taylor, and Robert Hutter, each serving as independent directors of Fund IX.
• · The outstanding shares of Fund IX and LLC shares are not traded on any securities market.
• · The special shareholder meeting is scheduled for July 16, 2026 at 9:00 a.m. Pacific Time.
• · The record date for voting is May 1, 2026.

17-06-2026

Two Roads Shared Trust filed a definitive proxy statement (DEF 14A) on June 17, 2026, to solicit shareholder approval for new investment advisory and sub-advisory agreements for the Simplify Affinity World Leaders Equity ETF. The prior adviser, Regents Park Funds, LLC, exited after its agreement expired on March 31, 2026, and Simplify Asset Management Inc. has been serving as interim adviser since April 1, 2026. The Board unanimously recommends voting FOR both proposals, and there is no change to the fund's investment objective, fee structure, or portfolio managers.

• · The Special Meeting of Shareholders will be held on August 4, 2026 at 1:00 p.m. Eastern time at the offices of Ultimus Fund Solutions, LLC, 80 Arkay Drive, Suite 110, Hauppauge, NY 11788.
• · The Prior Advisory Agreement was dated September 19, 2017 and expired on March 31, 2026.
• · The Interim Advisory Agreement took effect on April 1, 2026 and will terminate upon shareholder approval of the New Advisory Agreement or 150 days after March 31, 2026, whichever occurs first.
• · Simplify's principal business address is 10845 Griffith Peak Drive, Floor 2, Las Vegas, NV 89135.
• · Affinity has served as sub-adviser since 2018 and will continue under the New Sub-Advisory Agreement.
• · If shareholders do not approve the new agreements within 150 days, the Board will consider other alternatives for managing the fund's investments.

17-06-2026

Starwood Real Estate Income Trust filed a DEF 14A proxy statement for its 2026 annual meeting to be held virtually on August 11, 2026. Stockholders will vote on the election of ten director nominees and the ratification of Deloitte & Touche as independent auditor for the year ending December 31, 2026. As of the record date of May 13, 2026, the company had 172,810,820 Class S shares, 4,573,300 Class T shares, 24,332,392 Class D shares, and 185,383,502 Class I shares, for a total of 387,100,013 common shares outstanding. The board recommends voting FOR all director nominees and FOR auditor ratification.

• · The annual meeting will be held virtually on August 11, 2026 at 9:00 a.m. ET, with registration required by August 7, 2026 at 5:00 p.m. ET.
• · A quorum requires the presence of at least 50% of all votes entitled to be cast.
• · Abstentions and broker non-votes will count as votes AGAINST each director nominee; abstentions do not affect the auditor ratification proposal.
• · Stockholders can change or revoke a proxy by delivering a later-dated proxy or written revocation by August 10, 2026.